다운로드하려면 클릭
AbstractUp to 40% of patients with epidermal growt…
AbstractIntroduction: Osimertinib is a third-…
AbstractPurpose: Agonists of the stimulator o…
AbstractObjectives: The epidermal growth fact…
Editorial: Development of small molecule inhibitor…
AbstractA recently developed treatment strategy fo…
AbstractAdequate preclinical model and model estab…